{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:01:16Z","timestamp":1776769276715,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1067\/mjd.2003.323","type":"journal-article","created":{"date-parts":[[2003,6,4]],"date-time":"2003-06-04T20:09:55Z","timestamp":1054757395000},"page":"970-972","source":"Crossref","is-referenced-by-count":41,"title":["Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease"],"prefix":"10.1067","volume":"48","author":[{"given":"Christina K.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"O.Fred","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2003.323_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0889-8529(05)70299-1","article-title":"The pathogenesis of Graves' disease","volume":"27","author":"McIver","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1067\/mjd.2003.323_bib2","first-page":"536","author":"Burch","year":"1995"},{"key":"10.1067\/mjd.2003.323_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199401000-00001","article-title":"Dermopathy of Graves' disease (pretibial myxedema): review of 150 cases","volume":"73","author":"Fatourechi","year":"1994","journal-title":"Med"},{"key":"10.1067\/mjd.2003.323_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Graves' ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mjd.2003.323_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.1980.01640260081021","article-title":"Thyroid acropachy","volume":"166","author":"Goette","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.323_bib6","first-page":"791","article-title":"Tc-pyrophosphate scan and radiographic correlation in thyroid acropachy: case report","volume":"17","author":"Siegel","year":"1976","journal-title":"J Nucl Med"},{"key":"10.1067\/mjd.2003.323_bib7","first-page":"926","article-title":"Unusual manifestations of Graves' disease","volume":"47","author":"Gorman","year":"1972","journal-title":"Mayo Clin Proc"},{"key":"10.1067\/mjd.2003.323_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1620\/tjem.115.155","article-title":"Exophthalmus-myxoedema circumscriptum praetibiale-osteoarthropia hypertrophicans (E.M.O.) syndrome in Graves' disease: a review of eight cases reported in Japan","volume":"115","author":"Saito","year":"1975","journal-title":"Tohoku J Exp Med"},{"key":"10.1067\/mjd.2003.323_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/jc.78.2.256","article-title":"A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy","volume":"78","author":"Bahn","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/mjd.2003.323_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(05)62920-0","article-title":"Hypothyroidism","volume":"349","author":"Freeman","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.323_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/qjmed\/86.8.473","article-title":"Extrathyroidal complications of Graves' disease","volume":"86","author":"Weetman","year":"1993","journal-title":"Q J Med"},{"key":"10.1067\/mjd.2003.323_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/014107688607900312","article-title":"Thyrotoxicosis: gross acropachy and pretibial myxedema","volume":"79","author":"Shaheen","year":"1986","journal-title":"J R Soc Med"},{"key":"10.1067\/mjd.2003.323_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archderm.1973.01620160075024","article-title":"Pretibial myxedema and nonthyrotoxic thyroid disease","volume":"107","author":"Lynch","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.323_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(58)91238-8","article-title":"Gross digital clubbing and exophthamic ophthalmoplegia in thyroid disorders","volume":"2","author":"Freeman","year":"1958","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.323_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jcem-69-1-90","article-title":"Biological activity of autoantibodies associated with Graves' dermopathy","volume":"69","author":"Tao","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/mjd.2003.323_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1346-8138.1998.tb02394.x","article-title":"Pretibial myxedema with Graves' disease: a case report and review of Japanese literature","volume":"25","author":"Ishizawa","year":"1998","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2003.323_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1530\/acta.0.1290322","article-title":"Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema","volume":"129","author":"Chang","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"suppl","key":"10.1067\/mjd.2003.323_bib18","first-page":"63","article-title":"Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease","volume":"141","author":"Antonelli","year":"1992","journal-title":"Clin Ter"},{"key":"10.1067\/mjd.2003.323_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-4362.1997.00321.x","article-title":"Advances in the cutaneous manifestations of thyroid disease","volume":"36","author":"Heymann","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2003.323_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/thy.1996.6.41","article-title":"Is Graves' dermopathy a generalized disorder?","volume":"6","author":"Peacey","year":"1996","journal-title":"Thyroid"},{"key":"10.1067\/mjd.2003.323_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1530\/eje.0.1380368","article-title":"Effects of smoking on thyroid function","volume":"138","author":"Utiger","year":"1998","journal-title":"Soc Europ J Endocrinol"},{"key":"10.1067\/mjd.2003.323_bib22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0140-6736(90)91315-2","article-title":"Association between Graves' ophthalmopathy and smoking","volume":"335","author":"Shine","year":"1990","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.323_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/thy.1997.7.3","article-title":"TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema","volume":"7","author":"Stadlmayr","year":"1997","journal-title":"Thyroid"},{"key":"10.1067\/mjd.2003.323_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.304.6820.158","article-title":"Octreotide and Graves' ophthalmopathy and pretibial myxedema","volume":"304","author":"Chang","year":"1992","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2003.323_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/clin.1994.1059","article-title":"TSH and TSH receptor antibody binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of the entire TSH receptor","volume":"71","author":"Chang","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mjd.2003.323_bib26","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1210\/jc.81.12.4476","article-title":"Lack of an association between alleles of interleukin-1? and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population","volume":"81","author":"Cuddihy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1067\/mjd.2003.323_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0025-7125(16)32931-5","article-title":"Thyroid acropachy","volume":"52","author":"Kinsella","year":"1968","journal-title":"Med Clin North Am"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203004201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203004201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T23:42:19Z","timestamp":1584747739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962203004201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0190962203004201"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2003.323","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}